TPD52 and cancer: Moreover, cancer-derived SPOP mutants failed to decrease endogenous PrLZ protein abundance comparing to SPOP WT (Fig. 3e), thereby incapable of affecting the half-life (Fig. 3f, g) and ubiquitination (Fig. 3h) of PrLZ protein.